Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
IRRAS AB publishes Year End Report for the period January to December 2022 PR Newswire STOCKHOLM, Feb. 16, 2023 Commercial partnership underway to wrap up meaningful year of growth STOCKHOLM...
IRRAS AB publishes Year End Report for the period January to December 2022 PR Newswire STOCKHOLM, Feb. 16, 2023 Commercial partnership underway to wrap up meaningful year of growth STOCKHOLM...
IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis PR Newswire STOCKHOLM, Feb. 13, 2023...
IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis PR Newswire STOCKHOLM, Feb. 13, 2023...
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit PR Newswire STOCKHOLM, Dec. 12, 2022 IRRAS received US FDA 510(k) clearance for its class II next-generation...
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit PR Newswire STOCKHOLM, Dec. 12, 2022 IRRAS received US FDA 510(k) clearance for its class II next-generation...
IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System PR Newswire STOCKHOLM, Nov. 14, 2022 IRRAS has signed a commercial agreement with Medtronic...
IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System PR Newswire STOCKHOLM, Nov. 14, 2022 IRRAS has signed a commercial agreement with Medtronic...
IRRAS AB publishes Interim Report for the period January to September 2022 PR Newswire STOCKHOLM, Nov. 10, 2022 STOCKHOLM, Nov. 10, 2022 /PRNewswire/ -- Financial Runway Extended during Q3 as...
IRRAS AB publishes Interim Report for the period January to September 2022 PR Newswire STOCKHOLM, Nov. 10, 2022 STOCKHOLM, Nov. 10, 2022 /PRNewswire/ -- Financial Runway Extended during Q3 as...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 29.038 | 29.038 | 29.038 | 0 | 0 | DE |
| 4 | 0 | 0 | 29.038 | 29.038 | 29.038 | 0 | 0 | DE |
| 12 | 0 | 0 | 29.038 | 29.038 | 29.038 | 0 | 0 | DE |
| 26 | 0 | 0 | 29.038 | 29.038 | 29.038 | 0 | 0 | DE |
| 52 | 0 | 0 | 29.038 | 29.038 | 29.038 | 0 | 0 | DE |
| 156 | 0 | 0 | 29.038 | 29.038 | 29.038 | 1847 | 29.038 | DE |
| 260 | 0 | 0 | 29.038 | 29.038 | 29.038 | 1173 | 29.038 | DE |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
